Goralatide

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGoralatide
Drug Alias Namegoralatidum戈雷拉肽goralatidagoralatideSeraspenide +[8] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIpsen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIpsen Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantation

Other Information

ATC CodeN/A
Related LinksN/A